Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)

LEO Pharma

Status: Completed

Conditions: Scalp Psoriasis

Treatments: Drug: Xamiol® Gel

Study type: Observational

Funder types: Industry

Identifiers

NCT01052467

Treatment with Xamiol® Gel

Details and patient eligibility

About

This non-interventional, prospective, non-controlled study of Xamiol® Gel, a fixed combination of calcipotriol and betamethason dipropionate, shall investigate in daily routine the efficacy, tolerability and changes in quality-of-life parameters in patients with scalp psoriasis

Enrollment: 724 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with scalp psoriasis if a treatment with Xamiol® gel is planned anyway

Exclusion criteria

• Contraindications of Xamiol® Gel listed in the German package insert
• Pretreatment with Xamiol® within the last 4 weeks
• Systemic treatment of psoriasis
• UV light therapy